Audentes Therapeutics to Present at the ARM 5th Annual Cell & Gene Therapy Investor Day – Yahoo Finance
|
Audentes Therapeutics to Present at the ARM 5th Annual Cell & Gene Therapy Investor Day
Yahoo Finance SAN FRANCISCO, April 17, 2017 /PRNewswire/ — Audentes Therapeutics, Inc. (BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today … Zacks Investment Research Lowers Audentes Therapeutics Inc (BOLD) to Sell |
